Related Links

Current Releases
Stock Quote
Standard & Poor's
SEC Filings
Mailing List
Releases Archives
 

Powered by Business Wire

Opexa Therapeutics Headlines
02/03/2010 - 08:30 AM
Opexa to Present at the 12th Annual BIO CEO & Investor Conference on February 8, 2010
12/18/2009 - 06:42 AM
Translations Available
Opexa Therapeutics, Inc. annonce la clôture de son offre directe enregistrée de 5,1 millions de dollars
12/18/2009 - 01:32 AM
Translations Available
Resumen: Opexa Therapeutics, Inc. cierra oferta directa registrada de $5,1 millones
12/17/2009 - 09:37 PM
Translations Available
Samenvatting: Opexa Therapeutics, Inc. meldt sluiting van rechtstreeks aanbod van registeraandelen van 5,1 miljoen dollar
12/17/2009 - 01:13 PM
Translations Available
Opexa Therapeutics, Inc., gibt Abschluss von registrierter Direktplatzierung in Höhe von USD 5,1 Millionen bekannt
12/17/2009 - 08:30 AM
Translations Available
Riassunto: Opexa Therapeutics, Inc. annuncia la chiusura dell’offerta diretta registrata da 5,1 milioni di dollari
12/17/2009 - 08:30 AM
Translations Available
Opexa Therapeutics, Inc. Announces Closing of $5.1 Million Registered Direct Offering
12/14/2009 - 01:13 AM
Translations Available
オペクサ・セラピューティクス、510万ドルの株式売り出しを発表
12/12/2009 - 07:11 PM
Translations Available
Opexa Therapeutics, Inc.宣布发行510万美元证券
12/12/2009 - 06:46 PM
Translations Available
Opexa Therapeutics, Inc. annonce une offre de titres de 5,1 millions de dollars
12/11/2009 - 05:29 PM
Translations Available
Resumen: Opexa Therapeutics, Inc. anuncia oferta de obligaciones por valor de $5,1 millones
12/11/2009 - 05:24 PM
Translations Available
Samenvatting: Opexa Therapeutics kondigt aanbieding van 5,1 miljoen dollar aan obligaties aan
12/11/2009 - 05:21 PM
Translations Available
Riassunto: Opexa Therapeutics, Inc. annuncia un’offerta di titoli da 5,1 milioni di dollari
12/11/2009 - 05:21 PM
Translations Available
Opexa Therapeutics, Inc. gibt Wertpapierangebot über 5,1 Millionen US-Dollar bekannt
12/10/2009 - 09:23 AM
Translations Available
Opexa Therapeutics, Inc. Announces $5.1 Million Securities Offering
12/02/2009 - 08:00 AM
Seasoned Clinical Development Expert Joins Opexa to Lead Tovaxin® Development in Multiple Sclerosis
11/05/2009 - 08:30 AM
Opexa to Present at the Merriman Curhan Ford 6th Annual Investor Summit 2009 on November 10, 2009
11/04/2009 - 08:33 AM
Opexa Therapeutics Reports Third Quarter 2009 Financial Results and Corporate Update
09/23/2009 - 08:00 AM
Opexa Triggers Milestone Payment Under Recently Announced Stem Cell Agreement
09/22/2009 - 08:00 AM
Opexa to Present at the Wall Street Analyst Forum 20th Annual Analyst Conference
09/08/2009 - 07:30 AM
Opexa to Present at the Rodman & Renshaw 11th Annual Healthcare Conference September 11, 2009
09/08/2009 - 07:00 AM
Opexa Reports Additional Favorable Data with Tovaxin® for Multiple Sclerosis
08/13/2009 - 07:00 AM
Opexa Therapeutics Reports Second Quarter 2009 Financial Results and Corporate Update
08/10/2009 - 07:00 AM
Opexa Regains NASDAQ Compliance Following Stem Cell Agreement
08/09/2009 - 03:46 PM
Translations Available
Opexa gibt Vereinbarung mit führendem globalem Pharmaunternehmen zu Stammzellentechnologie bekannt
1 2 3 4 5 6
 
Next »
        Releases Archives
©2005 PharmaFrontiers Corp. All Rights Reserved
Design + Programming: BlausenLisi